Adenoviral-mediated gene transfer of ICP47 inhibits major histocompatibility complex class I expression on vascular cells in vitro

Louise Furukawa, Lucy S. Brevetti, Sandra E. Brady, David Johnson, Madison Ma, Theodore H. Welling, Louis M. Messina

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Purpose: Many viruses have evolved mechanisms to evade detection by the host immune system. The herpes simplex gene ICP47 encodes a protein that binds to the host antigen-processing transporter, inhibiting the formation of major histocompatibility complex class I (MHC-I) antigens in infected cells. MHC-I antigen expression is also important in acute allograft rejection. This study was designed to quantitate the effect of adenoviral-mediated gene transfer of ICP47 on MHC-I cell surface expression of human vascular cells. We hypothesized that the transduction of vascular cells with a replication- incompetent adenoviral vector that was expressing ICP47 (AdICP47) would inhibit constitutive and inducible MHC-I expression and thereby reduce the rate of cytolysis of ICP47-transduced vascular cells by sensitized cytotoxic T lymphocytes (CTL). Methods: A replication-incompetent adenoviral vector, AdICP47, was created to express ICP47 driven by the cytomegalovirus immediate early promoter. Cultured human vascular endothelial and smooth muscle cells and human dermal fibroblasts were transduced with either AdICP47 or the control empty vector AddLE1. Cell surface constitutive and γ-interferon- induced MHC-I expression were quantitated by flow cytometry. A standard 4- hour chromium release cytotoxicity assay was used to determine the percent cytolysis of transduced and nontransduced endothelial cells by sensitized CTL. Finally, to quantitate the specificity of the effect of ICP47 on MHC-I expression, adhesion molecule expression was quantitated in both transduced and nontransduced cells. Results: Constitutive MHC-I expression in AdICP47- transduced endothelial cells was inhibited by a mean of 84% ± 5% (SEM) in five experiments. After 48 hours of exposure to γ-interferon, AdICP47- transduced cells exhibited a mean of 66% ± 8% lower MHC-I expression than nontransduced cells. Similar inhibition in MHC-I expression was achieved in AdICP47-transduced vascular smooth muscle cells and dermal fibroblasts. Percent cytolysis of AdICP47-transduced endothelial cells by CTL was reduced by 72%. Finally, the specificity of the effect of transduction of ICP47 on vascular cell MHC-I expression was confirmed by a lack of significant change in either constitutive or tumor necrosis factor-induced vascular cell adhesion molecule/intercellular adhesion molecule expression. Conclusion: Transduction of vascular cells with AdICP47 strongly inhibits both constitutive and inducible MHC-I expression in human vascular cells. AdICP47- transduced cells exhibited a substantial reduction in cytolysis by CTL. Thus AdICP47 transduction holds promise as a technique to characterize the role of MHC-I expression in acute vascular allograft rejection in vivo and as a potential therapeutic intervention.

Original languageEnglish (US)
Pages (from-to)558-566
Number of pages9
JournalJournal of Vascular Surgery
Volume31
Issue number3
StatePublished - 2000
Externally publishedYes

Fingerprint

Major Histocompatibility Complex
Blood Vessels
Genes
Cytotoxic T-Lymphocytes
Histocompatibility Antigens Class I
Endothelial Cells
Vascular Smooth Muscle
In Vitro Techniques
Interferons
Smooth Muscle Myocytes
Allografts
Fibroblasts
Skin
Herpes Simplex
Vascular Cell Adhesion Molecule-1
Antigen Presentation
Cell Adhesion Molecules
Chromium
Cytomegalovirus
Immune System

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Furukawa, L., Brevetti, L. S., Brady, S. E., Johnson, D., Ma, M., Welling, T. H., & Messina, L. M. (2000). Adenoviral-mediated gene transfer of ICP47 inhibits major histocompatibility complex class I expression on vascular cells in vitro. Journal of Vascular Surgery, 31(3), 558-566.

Adenoviral-mediated gene transfer of ICP47 inhibits major histocompatibility complex class I expression on vascular cells in vitro. / Furukawa, Louise; Brevetti, Lucy S.; Brady, Sandra E.; Johnson, David; Ma, Madison; Welling, Theodore H.; Messina, Louis M.

In: Journal of Vascular Surgery, Vol. 31, No. 3, 2000, p. 558-566.

Research output: Contribution to journalArticle

Furukawa, Louise ; Brevetti, Lucy S. ; Brady, Sandra E. ; Johnson, David ; Ma, Madison ; Welling, Theodore H. ; Messina, Louis M. / Adenoviral-mediated gene transfer of ICP47 inhibits major histocompatibility complex class I expression on vascular cells in vitro. In: Journal of Vascular Surgery. 2000 ; Vol. 31, No. 3. pp. 558-566.
@article{92d69b7b554943bc80463aef9714d42b,
title = "Adenoviral-mediated gene transfer of ICP47 inhibits major histocompatibility complex class I expression on vascular cells in vitro",
abstract = "Purpose: Many viruses have evolved mechanisms to evade detection by the host immune system. The herpes simplex gene ICP47 encodes a protein that binds to the host antigen-processing transporter, inhibiting the formation of major histocompatibility complex class I (MHC-I) antigens in infected cells. MHC-I antigen expression is also important in acute allograft rejection. This study was designed to quantitate the effect of adenoviral-mediated gene transfer of ICP47 on MHC-I cell surface expression of human vascular cells. We hypothesized that the transduction of vascular cells with a replication- incompetent adenoviral vector that was expressing ICP47 (AdICP47) would inhibit constitutive and inducible MHC-I expression and thereby reduce the rate of cytolysis of ICP47-transduced vascular cells by sensitized cytotoxic T lymphocytes (CTL). Methods: A replication-incompetent adenoviral vector, AdICP47, was created to express ICP47 driven by the cytomegalovirus immediate early promoter. Cultured human vascular endothelial and smooth muscle cells and human dermal fibroblasts were transduced with either AdICP47 or the control empty vector AddLE1. Cell surface constitutive and γ-interferon- induced MHC-I expression were quantitated by flow cytometry. A standard 4- hour chromium release cytotoxicity assay was used to determine the percent cytolysis of transduced and nontransduced endothelial cells by sensitized CTL. Finally, to quantitate the specificity of the effect of ICP47 on MHC-I expression, adhesion molecule expression was quantitated in both transduced and nontransduced cells. Results: Constitutive MHC-I expression in AdICP47- transduced endothelial cells was inhibited by a mean of 84{\%} ± 5{\%} (SEM) in five experiments. After 48 hours of exposure to γ-interferon, AdICP47- transduced cells exhibited a mean of 66{\%} ± 8{\%} lower MHC-I expression than nontransduced cells. Similar inhibition in MHC-I expression was achieved in AdICP47-transduced vascular smooth muscle cells and dermal fibroblasts. Percent cytolysis of AdICP47-transduced endothelial cells by CTL was reduced by 72{\%}. Finally, the specificity of the effect of transduction of ICP47 on vascular cell MHC-I expression was confirmed by a lack of significant change in either constitutive or tumor necrosis factor-induced vascular cell adhesion molecule/intercellular adhesion molecule expression. Conclusion: Transduction of vascular cells with AdICP47 strongly inhibits both constitutive and inducible MHC-I expression in human vascular cells. AdICP47- transduced cells exhibited a substantial reduction in cytolysis by CTL. Thus AdICP47 transduction holds promise as a technique to characterize the role of MHC-I expression in acute vascular allograft rejection in vivo and as a potential therapeutic intervention.",
author = "Louise Furukawa and Brevetti, {Lucy S.} and Brady, {Sandra E.} and David Johnson and Madison Ma and Welling, {Theodore H.} and Messina, {Louis M.}",
year = "2000",
language = "English (US)",
volume = "31",
pages = "558--566",
journal = "Journal of Vascular Surgery",
issn = "0741-5214",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Adenoviral-mediated gene transfer of ICP47 inhibits major histocompatibility complex class I expression on vascular cells in vitro

AU - Furukawa, Louise

AU - Brevetti, Lucy S.

AU - Brady, Sandra E.

AU - Johnson, David

AU - Ma, Madison

AU - Welling, Theodore H.

AU - Messina, Louis M.

PY - 2000

Y1 - 2000

N2 - Purpose: Many viruses have evolved mechanisms to evade detection by the host immune system. The herpes simplex gene ICP47 encodes a protein that binds to the host antigen-processing transporter, inhibiting the formation of major histocompatibility complex class I (MHC-I) antigens in infected cells. MHC-I antigen expression is also important in acute allograft rejection. This study was designed to quantitate the effect of adenoviral-mediated gene transfer of ICP47 on MHC-I cell surface expression of human vascular cells. We hypothesized that the transduction of vascular cells with a replication- incompetent adenoviral vector that was expressing ICP47 (AdICP47) would inhibit constitutive and inducible MHC-I expression and thereby reduce the rate of cytolysis of ICP47-transduced vascular cells by sensitized cytotoxic T lymphocytes (CTL). Methods: A replication-incompetent adenoviral vector, AdICP47, was created to express ICP47 driven by the cytomegalovirus immediate early promoter. Cultured human vascular endothelial and smooth muscle cells and human dermal fibroblasts were transduced with either AdICP47 or the control empty vector AddLE1. Cell surface constitutive and γ-interferon- induced MHC-I expression were quantitated by flow cytometry. A standard 4- hour chromium release cytotoxicity assay was used to determine the percent cytolysis of transduced and nontransduced endothelial cells by sensitized CTL. Finally, to quantitate the specificity of the effect of ICP47 on MHC-I expression, adhesion molecule expression was quantitated in both transduced and nontransduced cells. Results: Constitutive MHC-I expression in AdICP47- transduced endothelial cells was inhibited by a mean of 84% ± 5% (SEM) in five experiments. After 48 hours of exposure to γ-interferon, AdICP47- transduced cells exhibited a mean of 66% ± 8% lower MHC-I expression than nontransduced cells. Similar inhibition in MHC-I expression was achieved in AdICP47-transduced vascular smooth muscle cells and dermal fibroblasts. Percent cytolysis of AdICP47-transduced endothelial cells by CTL was reduced by 72%. Finally, the specificity of the effect of transduction of ICP47 on vascular cell MHC-I expression was confirmed by a lack of significant change in either constitutive or tumor necrosis factor-induced vascular cell adhesion molecule/intercellular adhesion molecule expression. Conclusion: Transduction of vascular cells with AdICP47 strongly inhibits both constitutive and inducible MHC-I expression in human vascular cells. AdICP47- transduced cells exhibited a substantial reduction in cytolysis by CTL. Thus AdICP47 transduction holds promise as a technique to characterize the role of MHC-I expression in acute vascular allograft rejection in vivo and as a potential therapeutic intervention.

AB - Purpose: Many viruses have evolved mechanisms to evade detection by the host immune system. The herpes simplex gene ICP47 encodes a protein that binds to the host antigen-processing transporter, inhibiting the formation of major histocompatibility complex class I (MHC-I) antigens in infected cells. MHC-I antigen expression is also important in acute allograft rejection. This study was designed to quantitate the effect of adenoviral-mediated gene transfer of ICP47 on MHC-I cell surface expression of human vascular cells. We hypothesized that the transduction of vascular cells with a replication- incompetent adenoviral vector that was expressing ICP47 (AdICP47) would inhibit constitutive and inducible MHC-I expression and thereby reduce the rate of cytolysis of ICP47-transduced vascular cells by sensitized cytotoxic T lymphocytes (CTL). Methods: A replication-incompetent adenoviral vector, AdICP47, was created to express ICP47 driven by the cytomegalovirus immediate early promoter. Cultured human vascular endothelial and smooth muscle cells and human dermal fibroblasts were transduced with either AdICP47 or the control empty vector AddLE1. Cell surface constitutive and γ-interferon- induced MHC-I expression were quantitated by flow cytometry. A standard 4- hour chromium release cytotoxicity assay was used to determine the percent cytolysis of transduced and nontransduced endothelial cells by sensitized CTL. Finally, to quantitate the specificity of the effect of ICP47 on MHC-I expression, adhesion molecule expression was quantitated in both transduced and nontransduced cells. Results: Constitutive MHC-I expression in AdICP47- transduced endothelial cells was inhibited by a mean of 84% ± 5% (SEM) in five experiments. After 48 hours of exposure to γ-interferon, AdICP47- transduced cells exhibited a mean of 66% ± 8% lower MHC-I expression than nontransduced cells. Similar inhibition in MHC-I expression was achieved in AdICP47-transduced vascular smooth muscle cells and dermal fibroblasts. Percent cytolysis of AdICP47-transduced endothelial cells by CTL was reduced by 72%. Finally, the specificity of the effect of transduction of ICP47 on vascular cell MHC-I expression was confirmed by a lack of significant change in either constitutive or tumor necrosis factor-induced vascular cell adhesion molecule/intercellular adhesion molecule expression. Conclusion: Transduction of vascular cells with AdICP47 strongly inhibits both constitutive and inducible MHC-I expression in human vascular cells. AdICP47- transduced cells exhibited a substantial reduction in cytolysis by CTL. Thus AdICP47 transduction holds promise as a technique to characterize the role of MHC-I expression in acute vascular allograft rejection in vivo and as a potential therapeutic intervention.

UR - http://www.scopus.com/inward/record.url?scp=0034021769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034021769&partnerID=8YFLogxK

M3 - Article

C2 - 10709070

AN - SCOPUS:0034021769

VL - 31

SP - 558

EP - 566

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

SN - 0741-5214

IS - 3

ER -